Karen Richards

588 total citations
13 papers, 477 citations indexed

About

Karen Richards is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Karen Richards has authored 13 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Karen Richards's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Karen Richards is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Karen Richards collaborates with scholars based in United States and Japan. Karen Richards's co-authors include Thomayant Prueksaritanont, Michael Tanen, Thomas W. Doebber, Alan D. Adams, Richard S. Surwit, G M Thompson, Alex Elbrecht, Joel P. Berger, Gaochao Zhou and John Ventre and has published in prestigious journals such as Biochemistry, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Karen Richards

12 papers receiving 458 citations

Peers

Countries citing papers authored by Karen Richards

Since Specialization

Citations

This map shows the geographic impact of Karen Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Richards more than expected).

Fields of papers citing papers by Karen Richards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Richards. The network helps show where Karen Richards may publish in the future.

Co-authorship network of co-authors of Karen Richards

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Richards. A scholar is included among the top collaborators of Karen Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Richards. Karen Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Goal-Directed Versus Self-Directed Valsalva Maneuver in Patients With Hypertrophic Cardiomyopathy on Cardiac Myosin Inhibitor Therapy 2025 ·JACC Advances ·Aakash Bavishi, Marc P. M. Soutar, (unknown), Heather Speer, (unknown), (unknown), (unknown), Karen Richards, (unknown), (unknown)	1
2	Efficacy of Cardiac Myosin Inhibition in Patients After Septal Reduction Therapy 2024 ·The American Journal of Cardiology ·Aakash Bavishi, (unknown), Marc P. M. Soutar, (unknown), Heather Speer, (unknown), Karen Richards, (unknown), Matthew W. Martinez	0
3	Mavacamten Short-Term Hemodynamic, Functional, and Electrocardiographic Outcomes 2023 ·JACC Advances ·Omar Abdelfattah, (unknown), (unknown), Karen Richards, (unknown), Matthew W. Martinez	8
4	CYP2C75-Involved Autoinduction of Metabolism in Rhesus Monkeys of Methyl 3-Chloro-3′-fluoro-4′-{(1 R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1′-biphenyl-2-carboxylate (MK-0686), a Bradykinin B1 Receptor Antagonist 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Cuyue Tang, Brian Carr, (unknown), Bennett Ma, (unknown), Yuhsin Kuo, (unknown), (unknown), Karen Richards, (unknown), Edward J. Carlini, Christina N. Di Marco, Scott D. Kuduk, Nathan X. Yu, Conrad E. Raab, Tom Rushmore, Clay B. Frederick, Mark G. Bock, Thomayant Prueksaritanont	6
5	Compendium of gene expression profiles comprising a baseline model of the human liver drug metabolism transcriptome 2006 ·Xenobiotica ·J. Greg Slatter, Ian E. Templeton, John C. Castle, Amit Kulkarni, Thomas H. Rushmore, Karen Richards, Yudong D. He, Xudong Dai, (unknown), (unknown), Roger G. Ulrich	26
6	In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies 2006 ·Drug Metabolism and Disposition ·Thomayant Prueksaritanont, Yuhsin Kuo, Cuyue Tang, Chunze Li, Yue Qiu, Bing Lu, (unknown), Karen Richards, Brian Carr, Jiunn H. Lin	22
7	Interconversion Pharmacokinetics of Simvastatin and its Hydroxy Acid in Dogs: Effects of Gemfibrozil 2005 ·Pharmaceutical Research ·Thomayant Prueksaritanont, Yue Qiu, (unknown), (unknown), (unknown), Karen Richards, Jiunn H. Lin	29
8	INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY 2005 ·Drug Metabolism and Disposition ·Christopher R. Gibson, Charles C. Lin, Rominder Singh, (unknown), Karen Richards, (unknown), (unknown), (unknown), Edward J. Carlini, (unknown), Conrad E. Raab, (unknown), (unknown), (unknown), (unknown), Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie, Thomas H. Rushmore	5
9	Comparative Effects of Fibrates on Drug Metabolizing Enzymes in Human Hepatocytes 2005 ·Pharmaceutical Research ·Thomayant Prueksaritanont, Karen Richards, Yue Qiu, (unknown), (unknown), Chunze Li, (unknown), Edward J. Carlini	60
10	Using real‐time quantitative TaqMan RT‐PCR to evaluate the role of dexamethasone in gene regulation of rat P‐glycoproteins mdr1a/1b and cytochrome P450 3A1/2 2004 ·Journal of Pharmaceutical Sciences ·Mei Qin, Karen Richards, (unknown), (unknown), Anne Taylor, Masayo Yamazaki, Thomayant Prueksaritanont, Jiunn H. Lin, Jerome Hochman	37
11	Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator 2003 ·Molecular Endocrinology ·Joel P. Berger, Ann Petro, Karen L. MacNaul, Linda J Kelly, Bei B. Zhang, Karen Richards, Alex Elbrecht, Bruce A. Johnson, Gaochao Zhou, Thomas W. Doebber, Chhabi Biswas, (unknown), (unknown), Michael Tanen, G M Thompson, John Ventre, Alan D. Adams, Ralph Mosley, Richard S. Surwit, David E. Moller	271
12	Mechanism of Inhibition of Porcine Leukocyte 12-Lipoxygenase by the Isoform-Specific Inhibitor 4-(2-Oxapentadeca-4-yne)phenylpropanoic Acid 1999 ·Biochemistry ·Karen Richards, John S. Moody, Lawrence J. Marnett	4
13	Leukocyte 12-Lipoxygenase: Expression, Purification, and Investigation of the Role of Methionine Residues in Turnover-Dependent Inactivation and 5,8,11,14-Eicosatetraynoic Acid Inhibition 1997 ·Biochemistry ·Karen Richards, Lawrence J. Marnett	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact